Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 994-999, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, D.
Right arrow Articles by Hall, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, D.
Right arrow Articles by Hall, T. C.

The Reduction of Folate and of Dihydrofolate by Homogenates of Leukocytes from Patients with Leukemia or with Myeloid Metaplasia1

DeWayne Roberts and Thomas C. Hall

Laboratories of Pharmacology, Children's Cancer Research Foundation, and Departments of Pathology and Medicine, Harvard Medical School, Boston, Massachusetts 02115

Homogenates of human leukocytes reduced dihydrofolate more rapidly than folate. A correlation was observed between the assay of the enzyme with folate and with dihydrofolate. Homogenates of cells from patients receiving methotrexate reduced dihydrofolate much more rapidly than folate. Uninhibited enzyme was observed with both substrates in some homogenates of cells from patients receiving methotrexate. The level of enzyme activity in chronic myelogenous leukemia was correlated with the white blood cell count of the patient. Low levels of enzyme activity were observed in leukocytes from patients with myeloid metaplasia.

1 This investigation was supported by Contract No. PH-43-62-169 from the Cancer Chemotherapy National Service Center of the National Cancer Institute and by Grant No. 6516 from the NIH.

Received 8/ 5/66. Accepted 1/ 9/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.